About: Determination of imatinib in plasma by high performance capillary electrophoresis     Goto   Sponge   NotDistinct   Permalink

An Entity of Type : http://linked.opendata.cz/ontology/domain/vavai/Vysledek, within Data Space : linked.opendata.cz associated with source document(s)

AttributesValues
rdf:type
Description
  • Imatinib mesylate (IM) is an inhibitor of tyrosine kinase Abl, Bcr-Abl and c-kit used for targeted treatment in haematology and oncology. Recent studies described association of through IM plasma levels with cytogenetic and molecular response in patients with chronnic myeloid leukaemia. There is evidence that inclusion of plasma druh levels measurement may be important for successful management of resistance to IM.
  • Imatinib mesylate (IM) is an inhibitor of tyrosine kinase Abl, Bcr-Abl and c-kit used for targeted treatment in haematology and oncology. Recent studies described association of through IM plasma levels with cytogenetic and molecular response in patients with chronnic myeloid leukaemia. There is evidence that inclusion of plasma druh levels measurement may be important for successful management of resistance to IM. (en)
Title
  • Determination of imatinib in plasma by high performance capillary electrophoresis
  • Determination of imatinib in plasma by high performance capillary electrophoresis (en)
skos:prefLabel
  • Determination of imatinib in plasma by high performance capillary electrophoresis
  • Determination of imatinib in plasma by high performance capillary electrophoresis (en)
skos:notation
  • RIV/61989592:15110/08:10224403!RIV12-MSM-15110___
http://linked.open...avai/riv/aktivita
http://linked.open...avai/riv/aktivity
  • I
http://linked.open...iv/cisloPeriodika
  • 1
http://linked.open...vai/riv/dodaniDat
http://linked.open...aciTvurceVysledku
http://linked.open.../riv/druhVysledku
http://linked.open...iv/duvernostUdaju
http://linked.open...titaPredkladatele
http://linked.open...dnocenehoVysledku
  • 362960
http://linked.open...ai/riv/idVysledku
  • RIV/61989592:15110/08:10224403
http://linked.open...riv/jazykVysledku
http://linked.open.../riv/klicovaSlova
  • chronic myeloid leukemia; imatinib mesylate (IM) (en)
http://linked.open.../riv/klicoveSlovo
http://linked.open...odStatuVydavatele
  • IT - Italská republika
http://linked.open...ontrolniKodProRIV
  • [5C613F8AD3B4]
http://linked.open...i/riv/nazevZdroje
  • Haematologica: the hematology journal
http://linked.open...in/vavai/riv/obor
http://linked.open...ichTvurcuVysledku
http://linked.open...cetTvurcuVysledku
http://linked.open...UplatneniVysledku
http://linked.open...v/svazekPeriodika
  • 93
http://linked.open...iv/tvurceVysledku
  • Faber, Edgar
  • Indrák, Karel
  • Adam, Tomáš
  • Friedecký, David
  • Míčová, D.
issn
  • 0390-6078
number of pages
http://localhost/t...ganizacniJednotka
  • 15110
Faceted Search & Find service v1.16.118 as of Jun 21 2024


Alternative Linked Data Documents: ODE     Content Formats:   [cxml] [csv]     RDF   [text] [turtle] [ld+json] [rdf+json] [rdf+xml]     ODATA   [atom+xml] [odata+json]     Microdata   [microdata+json] [html]    About   
This material is Open Knowledge   W3C Semantic Web Technology [RDF Data] Valid XHTML + RDFa
OpenLink Virtuoso version 07.20.3240 as of Jun 21 2024, on Linux (x86_64-pc-linux-gnu), Single-Server Edition (126 GB total memory, 58 GB memory in use)
Data on this page belongs to its respective rights holders.
Virtuoso Faceted Browser Copyright © 2009-2024 OpenLink Software